scholarly article | Q13442814 |
P50 | author | José Pérez de los Cobos | Q52290637 |
Carlos Blanco | Q56089029 | ||
Bridget F. Grant | Q85286202 | ||
Deborah S Hasin | Q88070100 | ||
Mayumi Okuda | Q90566067 | ||
Catalina Lopez-Quintero | Q114403697 | ||
P2093 | author name string | Shuai Wang | |
P2860 | cites work | Prevalence, Correlates, and Disability of Personality Disorders in the United States | Q22241105 |
Nicotine chemistry, metabolism, kinetics and biomarkers | Q24632647 | ||
The influence of DeltaFosB in the nucleus accumbens on natural reward-related behavior | Q24642930 | ||
Distinct patterns of DeltaFosB induction in brain by drugs of abuse | Q24645131 | ||
Epigenetic mechanisms in drug addiction | Q24645709 | ||
Disruption of the neurexin 1 gene is associated with schizophrenia | Q24647095 | ||
Marijuana and cannabinoid regulation of brain reward circuits | Q24671514 | ||
The Structure of Genetic and Environmental Risk Factors for Common Psychiatric and Substance Use Disorders in Men and Women | Q28109330 | ||
From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol | Q28211980 | ||
Psychiatric disorders and stages of smoking | Q28237141 | ||
Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001 | Q28241400 | ||
Psychiatric genetics: progress amid controversy | Q28284253 | ||
Rapid induction of behavioral and neurochemical tolerance to cocaethylene, a model compound for agonist therapy of cocaine dependence | Q28372820 | ||
Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers | Q30435517 | ||
New insights into the genetics of addiction | Q30435949 | ||
The role of CRF and CRF-related peptides in the dark side of addiction | Q30476985 | ||
The genetic components of alcohol and nicotine co-addiction: from genes to behavior | Q30489302 | ||
Smoking, Genetics and Schizophrenia: Evidence for Self Medication | Q30491841 | ||
Pathways to adult marijuana and cocaine use: a prospective study of African Americans from age 6 to 42 | Q33608546 | ||
Heritability and a genome-wide linkage analysis of a Type II/B cluster construct for cannabis dependence in an American Indian community | Q33772486 | ||
Alcohol criteria endorsement and psychiatric and drug use disorders among DUI offenders: greater severity among women and multiple offenders | Q33791873 | ||
Nasal mucosal versus gastrointestinal absorption of nasally administered cocaine | Q33914898 | ||
Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study | Q34220050 | ||
Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q34338064 | ||
Metabolism and disposition kinetics of nicotine | Q34398241 | ||
Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q34456401 | ||
Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions | Q34456676 | ||
Age at onset of alcohol use and its association with DSM-IV alcohol abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey | Q34459517 | ||
Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability. | Q34536352 | ||
Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictions | Q34555160 | ||
Role of variability in explaining ethanol pharmacokinetics: research and forensic applications | Q35029490 | ||
Understanding polydrug use: review of heroin and cocaine co-use | Q35030844 | ||
Neurodevelopment, impulsivity, and adolescent gambling | Q35084944 | ||
"Unequal opportunity": neighbourhood disadvantage and the chance to buy illegal drugs | Q35414519 | ||
Models of comorbidity for multifactorial disorders. | Q35644460 | ||
Differences in onset and persistence of substance abuse and dependence among whites, blacks, and Hispanics. | Q35880009 | ||
Neurobiologic processes in drug reward and addiction | Q35894612 | ||
The epidemiology of dual diagnosis | Q35958291 | ||
Why does the rapid delivery of drugs to the brain promote addiction? | Q36024367 | ||
The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample | Q36465741 | ||
Tobacco addiction | Q36519493 | ||
Tobacco use and dependence in Asian Americans: a review of the literature | Q36761994 | ||
Adult tobacco use among racial and ethnic groups living in the United States, 2002-2005 | Q36790659 | ||
Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer | Q37008114 | ||
Neurobiology of nicotine addiction: implications for smoking cessation treatment | Q37110433 | ||
Does the 'gateway' matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication. | Q37122068 | ||
Predictors of illicit substance dependence among individuals with alcohol dependence | Q37123029 | ||
The importance of timing of transitions for risk of regular smoking and nicotine dependence | Q37138256 | ||
A short review on the aetiology and pathophysiology of alcoholism | Q37201073 | ||
Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits | Q37249662 | ||
Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disorders | Q37384809 | ||
Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions | Q37397699 | ||
The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q39742527 | ||
Surveillance of drug use among American Indian adolescents: patterns over 25 years | Q40510169 | ||
Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-up | Q40668156 | ||
Nicotine delivery kinetics and abuse liability | Q40782278 | ||
Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey | Q40992443 | ||
Multiple substance use among young males | Q43449886 | ||
Nicotine dependence in the United States: prevalence, trends, and smoking persistence | Q43730101 | ||
Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine | Q43982307 | ||
The validity of DSM-IV alcohol dependence: what do we know and what do we need to know? | Q44327693 | ||
Psychiatric comorbidity of smoking and nicotine dependence | Q44484505 | ||
The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample | Q44487795 | ||
Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults | Q44632998 | ||
Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q44634738 | ||
Cannabis use and psychosis: a longitudinal population-based study. | Q44820509 | ||
Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q44832144 | ||
Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females | Q44900954 | ||
The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample | Q44907459 | ||
The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. | Q44934071 | ||
Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey | Q44986547 | ||
Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. | Q45099615 | ||
Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population | Q45115352 | ||
Transitions from first substance use to substance use disorders in adolescence: is early onset associated with a rapid escalation? | Q46392666 | ||
Heritability of substance dependence in a native American population | Q46495959 | ||
Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001. | Q46535042 | ||
Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control study | Q46594088 | ||
Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey | Q46683000 | ||
Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. | Q46782998 | ||
The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. | Q47692512 | ||
Is there a progression from abuse disorders to dependence disorders? | Q47907103 | ||
Male-female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol | Q48654160 | ||
The epidemiology of DSM-IV specific phobia in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. | Q51763750 | ||
Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. | Q51907586 | ||
The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. | Q52011224 | ||
Perceived discrimination and substance use in African American parents and their children: a panel study. | Q55038322 | ||
Unfair treatment, racial/ethnic discrimination, ethnic identification, and smoking among Asian Americans in the National Latino and Asian American Study. | Q55048301 | ||
Comorbidity of substance use disorders with mood and anxiety disorders | Q57188031 | ||
Explaining recent increases in students' marijuana use: impacts of perceived risks and disapproval, 1976 through 1996 | Q57729330 | ||
Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey | Q71704834 | ||
Perceived discrimination and early substance abuse among American Indian children | Q77603957 | ||
P433 | issue | 1-2 | |
P304 | page(s) | 120-130 | |
P577 | publication date | 2010-12-08 | |
P1433 | published in | Drug and Alcohol Dependence | Q5308875 |
P1476 | title | Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) | |
P478 | volume | 115 |
Q92016219 | A Contagion Model for Within-Family Transmission of Drug Abuse |
Q57032950 | A Developmental Cascade Model for Early Adolescent Onset Substance Use: The Role of Early Childhood Stress |
Q88075615 | A Life Course Approach to Understanding Racial/Ethnic Differences in Transitions Into and Out of Alcohol Problems |
Q39245261 | A Meta-analysis of the Effectiveness of Interactive Middle School Cannabis Prevention Programs |
Q93086822 | A Rapid Response Electrochemical Biosensor for Detecting Thc In Saliva |
Q58088419 | A Survey of Cannabis Acute Effects and Withdrawal Symptoms: Differential Responses Across User Types and Age |
Q64284395 | A commentary on the medicinal use of marijuana |
Q40485915 | A longitudinal study predicting adolescent tobacco, alcohol, and cannabis use by behavioral characteristics of close friends. |
Q37157966 | A multistep general theory of transition to addiction. |
Q38804078 | A review of epidemiologic research on smoking behavior among persons with alcohol and illicit substance use disorders |
Q39286561 | Addiction as a BAD, a Behavioral Allocation Disorder. |
Q58734455 | Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood |
Q26861513 | Adverse health effects of marijuana use |
Q88438176 | Age of Cannabis Use Onset and Adult Drug Abuse Symptoms: A Prospective Study of Common Risk Factors and Indirect Effects |
Q53765984 | Age of initiation and substance use progression: A multivariate latent growth analysis. |
Q37164860 | Alcohol problems as a signal for sensitivity to nicotine dependence and future smoking |
Q47568308 | Aligning the ICD-11 classification of disorders due to substance use with global service needs |
Q90122490 | Assessment of Acute Motor Effects and Tolerance Following Self-Administration of Alcohol and Edible ∆9 -Tetrahydrocannabinol in Adolescent Male Mice |
Q47670201 | Association between Nonmedical Marijuana and Pain Reliever Uses among Individuals Aged 50. |
Q63684006 | Association of Cohort and Individual Substance Use With Risk of Transitioning to Drug Use, Drug Use Disorder, and Remission From Disorder |
Q50421061 | Associations Between Personality Disorders and Cannabis Use and Cannabis Use Disorder: A Population-Based Twin Study |
Q38619560 | Bars, Nightclubs, and Cancer Prevention: New Approaches to Reduce Young Adult Cigarette Smoking |
Q33835356 | Biological substrates of addiction. |
Q39131734 | Building smart cannabis policy from the science up. |
Q38750716 | Can we make cannabis safer? |
Q54967067 | Cannabidiol to Improve Mobility in People with Multiple Sclerosis. |
Q92401471 | Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases |
Q39004651 | Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases |
Q37630787 | Cannabis Epidemiology: A Selective Review. |
Q44349195 | Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States |
Q39150465 | Cannabis and Pain: A Clinical Review |
Q42682870 | Cannabis and alcohol use, affect and impulsivity in psychiatric out-patients' daily lives |
Q90626055 | Cannabis and mental illness: a review |
Q92898356 | Cannabis and the Current State of Treatment for Cannabis Use Disorder |
Q92310219 | Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives |
Q41989040 | Cannabis for the Treatment of Chronic Pain in the Era of an Opioid Epidemic: A Symposium-Based Review of Sociomedical Science |
Q88907845 | Cannabis regulatory science: risk-benefit considerations for mental disorders |
Q37615283 | Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study |
Q38711780 | Childhood traumatic experiences and the association with marijuana and cocaine use in adolescence through adulthood. |
Q36117825 | Cigarette Smoking and Risk of Alcohol Use Relapse Among Adults in Recovery from Alcohol Use Disorders |
Q101476198 | Cocaine addicted rats show reduced neural activity as revealed by manganese-enhanced MRI |
Q37395047 | Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects |
Q33865481 | Competing neurobehavioral decision systems theory of cocaine addiction: From mechanisms to therapeutic opportunities |
Q36415071 | Concurrent treatment of posttraumatic stress disorder and alcohol dependence: Predictors and moderators of outcome |
Q50654868 | Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. |
Q52317805 | Daily patterns of marijuana and alcohol co-use among individuals with alcohol and cannabis use disorders. |
Q35838639 | Demographic and psychological factors associated with lifetime cocaine use: An exploratory factor analysis of baseline questionnaires |
Q92262435 | Denying renal transplantation to an adolescent medical cannabis user: An ethical case study |
Q47675654 | Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service |
Q35859923 | Do placebo response rates from cessation trials inform on strength of addictions? |
Q30366949 | Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed |
Q34970338 | Dopamine D1 receptor gene variation modulates opioid dependence risk by affecting transition to addiction |
Q57743948 | Doubling down: increased risk-taking behavior following a loss by individuals with cocaine use disorder is associated with striatal and anterior cingulate dysfunction |
Q48065211 | Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial |
Q99563502 | Drug use disorder following early life exposure to tetrachloroethylene (PCE)-contaminated drinking water: a retrospective cohort study |
Q90191256 | Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder |
Q41551230 | ELSA 2016 Cohort: Alcohol, Tobacco, and Marijuana Use and Their Association with Age of Drug Use Onset, Risk Perception, and Social Norms in Argentinean College Freshmen. |
Q58101638 | Early Risk Factors for Daily Cannabis Use in Young Adults |
Q45057395 | Early maturation and substance use across adolescence and young adulthood: A longitudinal study of Finnish twins |
Q92718595 | Effect of adolescent androgen manipulation on psychosis-like behaviour in adulthood in BDNF heterozygous and control mice |
Q38750739 | Effects of a brief, parent-focused intervention for substance using adolescents and their sibling |
Q88789024 | Effects of amphetamine exposure during adolescence on behavior and prelimbic cortex neuron activity in adulthood |
Q90357485 | Effects of chronic cannabinoid exposure during adolescence on reward preference and mPFC activation in adulthood |
Q37200944 | Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions |
Q33799805 | Epidemiology of substance use in reproductive-age women |
Q39644977 | Estimated probability of becoming a case of drug dependence in relation to duration of drug-taking experience: a functional analysis approach |
Q90452923 | Estimating Long-Term Drinking Patterns for People with Lifetime Alcohol Use Disorder |
Q40247230 | Examining heterotypic continuity of psychopathology: a prospective national study |
Q46180560 | Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). |
Q48220353 | Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being |
Q60419105 | Female-male differences in alcohol dependence levels: Evidence on newly incident adolescent and young-adult drinkers in the United States, 2002-2014 |
Q52567089 | Frequency of Cannabis Use and Medical Cannabis Use Among Persons Living With HIV in the United States: Findings From a Nationally Representative Sample. |
Q36001683 | Frequent marijuana use, binge drinking and mental health problems among undergraduates |
Q33836185 | Gender and race/ethnicity differences for initiation of alcohol-related service use among persons with alcohol dependence |
Q47810718 | Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study |
Q36652144 | Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions |
Q24289498 | Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings |
Q92826769 | Genome-wide association study implicates CHRNA2 in cannabis use disorder |
Q34303884 | Greater elevation in risk for nicotine dependence per pack of cigarettes smoked among those with an anxiety disorder. |
Q89340947 | Impact of cannabis legalization on treatment and research priorities for cannabis use disorder |
Q46563220 | Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats. |
Q47115655 | Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users |
Q90115713 | Insights into the role of cannabis in the management of inflammatory bowel disease |
Q37129584 | Interaction between polygenic risk for cigarette use and environmental exposures in the Detroit Neighborhood Health Study |
Q36833477 | Investigating Progression in Substance Use Initiation Using a Discrete-Time Multiple Event Process Survival Mixture (MEPSUM) Approach |
Q47640713 | Investigating the mediational role of negative urgency in the anxiety sensitivity pathway to cannabis problems and dependence symptoms among postsecondary students. |
Q34521105 | Keep off the grass? Cannabis, cognition and addiction |
Q91973217 | Legalized Cannabis in Colorado Emergency Departments: A Cautionary Review of Negative Health and Safety Effects |
Q37731162 | Long-lasting memory deficits in mice withdrawn from cocaine are concomitant with neuroadaptations in hippocampal basal activity, GABAergic interneurons and adult neurogenesis |
Q60639478 | Longitudinal Methods in Substance Use Research |
Q46924688 | Longitudinal Studies on the Etiology of Cannabis Use Disorder: A Review |
Q37368453 | Longitudinal determinants of substance use disorders. |
Q38740886 | Longitudinal relationships of sleep and inhibitory control deficits to early adolescent cigarette and alcohol use. |
Q47637125 | Marijuana Use and Organ Transplantation: a Review and Implications for Clinical Practice. |
Q33773395 | Marijuana Use, Recent Marijuana Initiation, and Progression to Marijuana Use Disorder Among Young Male and Female Adolescents Aged 12-14 Living in US Households |
Q38824571 | Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys |
Q28069855 | Medical cannabis - the Canadian perspective |
Q90173408 | Medical cannabis for chronic pain: can it make a difference in pain management? |
Q34570676 | Medical marijuana: more questions than answers |
Q47903271 | Mental health differences between frequent cannabis users with and without dependence and the general population. |
Q47232576 | Minding the brain: the role of pharmacotherapy in substance-use disorder treatment |
Q36429054 | Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis |
Q89873651 | Mu-opioid antagonism in the treatment of cannabis use disorder |
Q55032013 | N-acetylcysteine: A potential treatment for substance use disorders. |
Q36927776 | Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse |
Q47943756 | Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study. |
Q47344258 | Nicotine increases anterior insula activation to expected and unexpected outcomes among nonsmokers |
Q38847765 | Pathways linking marijuana use to substance use problems among emerging adults: A prospective analysis of young Black men. |
Q43075592 | Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States |
Q37738986 | Patterns of marijuana and tobacco use associated with suboptimal self-rated health among US adult ever users of marijuana |
Q39114732 | Peer Network Counseling as Brief Treatment for Urban Adolescent Heavy Cannabis Users |
Q36368406 | Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders |
Q60313531 | Personal experience and attitudes of pain medicine specialists in Israel regarding the medical use of cannabis for chronic pain |
Q37679140 | Personality traits and vulnerability or resilience to substance use disorders. |
Q36625746 | Predictors of quit attempts and successful quit attempts in a nationally representative sample of smokers. |
Q33568885 | Prevalence & correlates of tobacco use among adolescents in Kerala, India. |
Q37658318 | Prevalence and correlates of alcohol and cannabis use disorders in the United States: results from the national longitudinal study of adolescent health |
Q41220943 | Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. |
Q47556136 | Prevalence of problematic cannabis use in Canada: Cross-sectional findings from the 2013 Canadian Tobacco, Alcohol and Drugs Survey. |
Q47555908 | Prevalence, Diagnosis, and Treatment Rates of Mood Disorders among Opioid Users under Criminal Justice Supervision. |
Q91578309 | Priming primary care providers to engage in evidence-based discussions about cannabis with patients |
Q45902136 | Prior alcohol use enhances vulnerability to compulsive cocaine self-administration by promoting degradation of HDAC4 and HDAC5. |
Q34435738 | Probability and predictors of the cannabis gateway effect: a national study |
Q37128199 | Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the National Epidemiologic Survey on Alcohol and Related Conditions |
Q36794523 | Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study. |
Q64245770 | Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence |
Q89685781 | Protocol for a feasibility study investigating the UCalgary's Cannabis Café: education and harm reduction initiative for postsecondary students |
Q90734187 | Psychoactive substance use among outpatients with severe mental illness: A comparative study |
Q36836847 | Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug? |
Q38605561 | Race/ethnicity and marijuana use in the United States: Diminishing differences in the prevalence of use, 2006-2015. |
Q34190594 | Race/ethnicity and sex differences in progression from drinking initiation to the development of alcohol dependence |
Q40509840 | Rapid transition from drinking to alcohol dependence among adolescent and young-adult newly incident drinkers in the United States, 2002-2013. |
Q37375052 | Rate of progression from first use to dependence on cocaine or opioids: a cross-substance examination of associated demographic, psychiatric, and childhood risk factors |
Q50561199 | Rats quit nicotine for a sweet reward following an extensive history of nicotine use. |
Q38599985 | Recent cannabis use among Veterans in the United States: Results from a national sample |
Q39524644 | Recreational marijuana use is not associated with worse outcomes after renal transplantation. |
Q37667076 | Relation among HPA and HPG neuroendocrine systems, transmissible risk and neighborhood quality on development of substance use disorder: results of a 10-year prospective study |
Q34099638 | Risk factors for anxiety disorders: common and specific effects in a national sample |
Q30316580 | Risks associated with the non-medicinal use of cannabis |
Q49263953 | Scientific Evidence for the Addictiveness of Tobacco and Smoking Cessation in Tobacco Litigation |
Q47573027 | Sex and gender differences in substance use disorders |
Q36157017 | Sex differences in behavior and neural development and their role in adolescent vulnerability to substance use |
Q89529732 | Sex- and Gender-Based Analysis in Cannabis Treatment Outcomes: A Systematic Review |
Q38676035 | Shaping vulnerability to addiction - the contribution of behavior, neural circuits and molecular mechanisms. |
Q34005873 | Stimulant dependence and stimulant-associated psychosis: clinical characteristics and age of onset in a native American community sample |
Q30433321 | Stress modulates illness-course of substance use disorders: a translational review |
Q59789689 | Subregional Hippocampal Thickness Abnormalities in Older Adults with a History of Heavy Cannabis Use |
Q35636292 | Telling true from false: cannabis users show increased susceptibility to false memories |
Q47552036 | Testing Genetic and Environmental Associations Between Personality Disorders and Cocaine Use: A Population-Based Twin Study |
Q36702297 | Testing the drug substitution switching-addictions hypothesis. A prospective study in a nationally representative sample |
Q36307812 | The Dutch Cannabis Dependence (CanDep) study on the course of frequent cannabis use and dependence: objectives, methods and sample characteristics. |
Q53424578 | The Effects of Nicotine and Tobacco use on Brain Reward Function: Interaction with Nicotine Dependence Severity. |
Q58707392 | The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity |
Q90576570 | The Pediatrician and Marijuana: An Era of Change |
Q38950639 | The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders |
Q47705555 | The association between adolescent cannabis use and anxiety: A parallel process analysis |
Q41105095 | The couple that smokes together: Dyadic marijuana use and relationship functioning during conflict. |
Q50111626 | The emerging marijuana retail environment: Key lessons learned from tobacco and alcohol retail research. |
Q64882775 | The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: Findings from the Australian National Survey on Mental Health and Wellbeing. |
Q37281788 | The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: a national study. |
Q62721385 | The pharmacokinetics and the pharmacodynamics of cannabinoids |
Q52313456 | The potential impact of cannabis legalization on the development of cannabis use disorders. |
Q35954701 | The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC). |
Q35952070 | The role of decision-making in cannabis-related problems among young adults |
Q89744537 | The role of negative affect in the persistence of nicotine dependence among alternative high school students: A latent growth curve analysis |
Q55397242 | Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. |
Q90396906 | Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada |
Q93363150 | Time since first cannabis use and 12-month prevalence of cannabis use disorder among youth and emerging adults in the United States |
Q33924603 | Time to connect: bringing social context into addiction neuroscience |
Q33852341 | Toward National Estimates of Effectiveness of Treatment for Substance Use |
Q34617902 | Toward a comprehensive developmental model of smoking initiation and nicotine dependence |
Q33607241 | Toward the Identification of a Specific Psychopathology of Substance Use Disorders |
Q37640693 | Towards a comprehensive developmental model of cannabis use disorders |
Q35855173 | Towards a comprehensive developmental model of pathological gambling |
Q37274656 | Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis |
Q88906456 | Transition to drug co-use among adolescent cannabis users: The role of decision-making and mental health |
Q30697158 | Transitioning from First Drug Use to Dependence Onset: Illustration of a Multiparametric Approach for Comparative Epidemiology |
Q91805014 | Transitions Through Stages of Alcohol Use, Use Disorder and Remission: Findings from Te Rau Hinengaro, The New Zealand Mental Health Survey |
Q36384293 | Transitions in illicit drug use status over 3 years: a prospective analysis of a general population sample |
Q52775809 | Trends in Daily Cannabis Use Among Cigarette Smokers: United States, 2002-2014. |
Q38990044 | Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder |
Q38635163 | Working memory and salivary brain-derived neurotrophic factor as developmental predictors of cocaine seeking in male and female rats. |
Q91972249 | [Addictive behaviors: clinical facts] |
Search more.